ArticleJournal for immunotherapy of cancer2025

Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice.

Alexandra Fauvre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.